Program
Marc Therrien, PhD
Professor, Department of Pathology and Cell Biology of the Faculty of Medicine of the Université de Montréal and Scientific Director of IRIC
20:30 – 21:00 | Juliet Daniel, PhD
Professor and Associate Dean of Research & External Relations, McMaster University
8:30 - 9:00 | Calvin Roskelley, PhD
Faculty of Medicine, Department of Cellular & Physiological Sciences, UBC
9:00 – 9:30 | Bebhinn Treanor, PhD
Associate Professor, Canada Research Chair, Department of Biological Sciences, University of Toronto-Scarborough
9:30 - 9:45 | Andrew Craig, PhD
Associate Professor, Department of Biomedical and Molecular Sciences, Queen's University; Director, Queen's Cancer Research Institute, Principal Investigator, CBG Division Queen's University
9:45 – 10:00 | Carrie Shemanko, PhD
Professor, Integrative Cell Biology, Biological Sciences, University of Calgary
10:30 – 11:00 | Sebastian Guettler, PhD
Deputy Head, Division of Structural Biology, The Institute of Cancer Research
11:00 – 11:30 | André Veillette, MD
Director, Molecular Oncology Research Unit, IRCM; Executive Director, Marathon of Hope Cancer Centres Network; Tier 1 Canada Research Chair in Immune System Signalling
11:30 – 11:45 | Karla Williams, PhD
Assistant Professor, Faculty of Pharmaceutical Sciences UBC
11:45 - 12:00 | Sponsor's talk. Peter Hurley
Business Development Manager, Olink Proteomics
19:00 – 19:30 | Sabine Elowe, PhD
Full professor, Department of Pediatrics, Faculty of Medicine, Université Laval
19:30 - 20:00 | Lisa Porter, PhD
Professor, Department of Biomedical Sciences, University of Windsor; Executive Director, WE-SPARK Health Institute
20:30 – 21:00 | Sébastien Carreno, PhD
Principal Investigator, Cellular Mechanisms of Morphogenesis during Mitosis and Cell Motility Research Unit, IRIC; Full Professor, Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal
21:00 - 21:30 | Savraj Grewal, PhD
Professor, Department of Biochemistry & Molecular Biology, University of Calgary
21:30 – 21:45 | Véronique Giroux, PhD
Professor, Faculté de médecine et des sciences de la santé, Université de Sherbrooke
21:45 – 22:00 | Joel Pearson, PhD
Assistant professor, Max Rady College of Medicine, Pharmacology and Therapeutics, Department of Pharmacology and Therapeutics, University of Manitoba; CancerCare Manitoba Research Institute
8:00 – 8:30 | Anne-Claude Gingras, PhD
Senior Investigator, Lunenfeld-Tanenbaum Research Institute
8:30 – 9:00 | Esther Verheyen, PhD
Professor, Molecular biology and biochemistry, Simon Fraser University
9:00 – 9:30 | Daniel Schramek, PhD
Investigator, Lunenfeld-Tanenbaum Research Institute; Associate Professor, Dept. of Molecular Genetics, University of Toronto, Canadian Research Chair in Functional Cancer Genomics
10:00 – 10:30 | Shoukat Dedhar, PhD
Professor, Biochemistry and Molecular Biology; Professor, Genetics Graduate Program; Senior Scientist, British Columbia Cancer Agency / British Columbia Cancer Research Centre
10:30 – 11:00 | Silvia Penuela, PhD
Associate Professor, Anatomy and Cell Biology, University of Western Ontario
11:00 – 11:30 | Robert Rottapel, PhD
Professor, Departments of Medicine, Immunology and Medical Biophysics, University of Toronto; Senior Investigator, OICR; Co-Leader, Ovarian Cancer Translational Research Initiative; Senior Scientist and Amgen Chair for Cancer Research, Princess Margaret Cancer Centre
11:30 – 11:45 | Wei Zhang, PhD
Assistant Professor and CIFAR Global Scholar, Department of Molecular and Cellular Biology, University of Guelph
11:45 – 12:00 | Mohan Malleshaiah, PhD
Assistant Research Professor, IRCM; Assistant Research Professor, Department of Biochemistry and Molecular Medicine, Université de Montréal; Adjunct Member, Division of Experimental Medicine in the Department of Medicine, McGill University
12:00 – 12:15 | Sponsor’s talk
STEMCELL
19:00 – 19:30 | Alexandre Orthwein, PhD*
Assistant Professor Department of Radiation Oncology ⎜Emory University School of Medicine Winship Cancer Institute of Emory University
19:30 – 20:00 | Janessa Laskin, MD, FRCPC*
Clinical Associate Professor, Medical Oncology, University of British Columbia
20:30 - 21:00 | Trevor Pugh, PhD, FACMG*
Senior Scientist, Princess Margaret Cancer Centre
21:00 – 21:30 | Morag Park, PhD*
Professor, Department of Biochemistry and Director, Rosalind and Morris Goodman Cancer Centre, McGill University
21:30 – 22:00 | Marathon of Hope Cancer Centres Network
André Veillette, Isabel Serrano, Natalie Szudy
8:00 – 8:30 | Matt Smith, PhD
Principal Investigator, Cancer Signalling and Structural Biology Research Unit, IRIC; Associate Professor, Department of Pathology and Cell Biology, Université de Montréal
8:30 – 9:00 | James Murphy, PhD
Professor, Head, Inflammation Division, Walter and Eliza Hall Institute of Medical Research, Australia
9:00 – 9:30 | Nathalie Lamarche-Vane, PhD
Professor, Anatomy and Cell Biology, McGill University
10:00 – 10:30 | Lois Mulligan, PhD
Professor, Pathology and Molecular Medicine, Queen’s University
10:30 – 11:00 | Michael Olson, PhD
Professor, Department of Chemistry and Biology, Toronto Metropolitan University; Tier 1 Canada Research Chair in Molecular Cell Biology
11:00 – 11:30 | James Woodgett, PhD*
President and Scientific Director, Terry Fox Research Institute Professor; Senior Scientist at Mount Sinai Hospital (Toronto), Sinai Health System
11:30 – 11:45 | Mélanie Laurin, PhD
Chercheure, Axe Oncologie, HDQ; professeure adjointe, Département biologie moléculaire, biochimie médicale et pathologie, Faculté de médecine, Université Laval
11:45 – 12:00 | Valentin Jaumouillé, PhD
Assistant Professor, Department of Molecular Biology and Biochemistry, Simon Fraser University
13:30 – 14:00 | Enfu Hui, PhD*
Associate Professor, Department of Cell and Developmental Biology, University of California, San Diego, USA
14:00 – 14:30 | Brad Nelson, PhD*
Professor, Medical Genetics, University of British Columbia
14:30 – 15:00 | Ian Watson, PhD*
Associate Professor, Department of Biochemistry, McGill University
15:00 – 15:30 | Daniela Quail, PhD*
Assistant Professor, Rosalind and Morris Goodman Cancer Centre and the Department of Physiology, McGill University
Marco Marra, PhD, FRS(C), FCAHS, OBC*
Professor, Department of Medical Genetics, University of British Columbia
